161 related articles for article (PubMed ID: 24039107)
1. Interleukin-28B and fibrosing cholestatic hepatitis in posttransplant hepatitis C: a case-control study and literature review.
Duarte-Rojo A; Budhraja V; Veldt BJ; Goldstein DD; Watt KD; Heimbach JK; McHutchison JG; Tillman HL; Poterucha JJ; Charlton MR
Liver Transpl; 2013 Dec; 19(12):1311-7. PubMed ID: 24039107
[TBL] [Abstract][Full Text] [Related]
2. Early viral load and recipient interleukin-28B rs12979860 genotype are predictors of the progression of hepatitis C after liver transplantation.
Graziadei IW; Zoller HM; Schloegl A; Nachbaur K; Pfeiffer KP; Mark W; Mikuz G; Pratschke J; Margreiter R; Vogel W
Liver Transpl; 2012 Jun; 18(6):671-9. PubMed ID: 22298465
[TBL] [Abstract][Full Text] [Related]
3. IL-28B rs12979860 C/T allele distribution in patients with liver cirrhosis: role in the course of chronic viral hepatitis and the development of HCC.
Fabris C; Falleti E; Cussigh A; Bitetto D; Fontanini E; Bignulin S; Cmet S; Fornasiere E; Fumolo E; Fangazio S; Cerutti A; Minisini R; Pirisi M; Toniutto P
J Hepatol; 2011 Apr; 54(4):716-22. PubMed ID: 21146242
[TBL] [Abstract][Full Text] [Related]
4. Fibrosing cholestatic hepatitis after successful interferon and ribavirin therapy for recurrent hepatitis C post living related liver transplantation: a case report.
Yamamoto T; Tanaka S; Uenishi T; Kanazawa A; Kubo S; Hirohashi K
Osaka City Med J; 2014 Dec; 60(2):95-100. PubMed ID: 25803885
[TBL] [Abstract][Full Text] [Related]
5. Role of serum level and genetic variation of IL-28B in interferon responsiveness and advanced liver disease in chronic hepatitis C patients.
Alborzi A; Hashempour T; Moayedi J; Musavi Z; Pouladfar G; Merat S
Med Microbiol Immunol; 2017 Apr; 206(2):165-174. PubMed ID: 28214926
[TBL] [Abstract][Full Text] [Related]
6. Fibrosing cholestatic hepatitis developing within one month after living donor liver transplantation for chronic hepatitis C-related cirrhosis: a case report.
Murakami K; Kawagishi N; Ishida K; Sekiguchi S; Fujishima F; Sasano H; Ohuchi N
Transplant Proc; 2014 Apr; 46(3):995-8. PubMed ID: 24767401
[TBL] [Abstract][Full Text] [Related]
7. Recipient interleukin-28B Rs12979860 C/T polymorphism and acute cellular rejection after liver transplantation: role of the calcineurin inhibitor used.
Bitetto D; Fabris C; Falleti E; Fornasiere E; Avellini C; Cmet S; Cussigh A; Fontanini E; Pirisi M; Corradini SG; Merli M; Molinaro A; Toniutto P
Transplantation; 2012 May; 93(10):1038-44. PubMed ID: 22495472
[TBL] [Abstract][Full Text] [Related]
8. CC genotype donors for the interleukin-28B single nucleotide polymorphism are associated with better outcomes in hepatitis C after liver transplant.
Firpi RJ; Dong H; Clark VC; Soldevila-Pico C; Morelli G; Cabrera R; Norkina O; Shuster JJ; Nelson DR; Liu C
Liver Int; 2013 Jan; 33(1):72-8. PubMed ID: 23107586
[TBL] [Abstract][Full Text] [Related]
9. IL-28B rs12979860 polymorphism affect the course of chronic hepatitis and the development of HCC in Egyptian patients with hepatitis C type 4.
Attallah AM; Omran D; Marie MS; Abdelrazek M; Salama A; El Essawey R; Mobarak L; Maklad S; Omar A
Br J Biomed Sci; 2018 Oct; 75(4):157-162. PubMed ID: 29914308
[TBL] [Abstract][Full Text] [Related]
10. Relationship between the interleukin-28b gene polymorphism and the histological severity of hepatitis C virus-induced graft inflammation and the response to antiviral therapy after liver transplantation.
Eurich D; Boas-Knoop S; Ruehl M; Schulz M; Carrillo ED; Berg T; Neuhaus R; Neuhaus P; Neumann UP; Bahra M
Liver Transpl; 2011 Mar; 17(3):289-98. PubMed ID: 21384511
[TBL] [Abstract][Full Text] [Related]
11. Long-term outcomes of direct acting antivirals in post-transplant advanced hepatitis C virus recurrence and fibrosing cholestatic hepatitis.
Vukotic R; Conti F; Fagiuoli S; Morelli MC; Pasulo L; Colpani M; Foschi FG; Berardi S; Pianta P; Mangano M; Donato MF; Malinverno F; Monico S; Tamè M; Mazzella G; Belli LS; Viganò R; Carrai P; Burra P; Russo FP; Lenci I; Toniutto P; Merli M; Loiacono L; Iemmolo R; Degli Antoni AM; Romano A; Picciotto A; Rendina M; Andreone P;
J Viral Hepat; 2017 Oct; 24(10):858-864. PubMed ID: 28370880
[TBL] [Abstract][Full Text] [Related]
12. Successful treatment of fibrosing cholestatic hepatitis after liver transplantation.
Cimsit B; Assis D; Caldwell C; Arvelakis A; Taddei T; Kulkarni S; Schilsky M; Emre S
Transplant Proc; 2011 Apr; 43(3):905-8. PubMed ID: 21486625
[TBL] [Abstract][Full Text] [Related]
13. Increased hepatic progenitor cell response and ductular reaction in patients with severe recurrent HCV post-liver transplantation.
Sclair SN; Fiel MI; Wu HS; Doucette J; Aloman C; Schiano TD
Clin Transplant; 2016 Jun; 30(6):722-30. PubMed ID: 27027987
[TBL] [Abstract][Full Text] [Related]
14. Fibrosing Cholestatic Hepatitis in a Complicated Case of an Adult Recipient After Liver Transplantation: Diagnostic Findings and Therapeutic Dilemma.
Hori T; Onishi Y; Kamei H; Kurata N; Ishigami M; Ishizu Y; Ogura Y
Am J Case Rep; 2016 Aug; 17():597-604. PubMed ID: 27545580
[TBL] [Abstract][Full Text] [Related]
15. Biliary strictures after liver transplantation: role of interleukin 28B genotypes in cyclosporine treated.
Toniutto P; Bitetto D; Falleti E; Vadalà S; Cmet S; Cussigh A; Bulajic M; Zilli M; Fabris C
Int J Surg; 2014 Oct; 12(10):1082-7. PubMed ID: 25219480
[TBL] [Abstract][Full Text] [Related]
16. Different distributions of hepatitis C virus genotypes among HIV-infected patients with acute and chronic hepatitis C according to interleukin-28B genotype.
Neukam K; Nattermann J; Rallón N; Rivero A; Caruz A; Macías J; Vogel M; Benito J; Camacho A; Mira J; Schwarze-Zander C; Barreiro P; Martínez A; Rockstroh J; Soriano V; Pineda J
HIV Med; 2011 Sep; 12(8):487-93. PubMed ID: 21375685
[TBL] [Abstract][Full Text] [Related]
17. Role of IL-28B genetic variants in HCV-related liver disease severity in patients with different viral genotypes.
Huang CI; Huang CF; Yeh ML; Lin YH; Liang PC; Liu SV; Hsieh MH; Lin ZY; Chen SC; Huang JF; Chuang WL; Dai CY; Yu ML
Medicine (Baltimore); 2018 Mar; 97(10):e9782. PubMed ID: 29517696
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-28B polymorphism in hepatitis C and liver transplantation.
Duarte-Rojo A; Deneke MG; Charlton MR
Liver Transpl; 2013 Jan; 19(1):49-58. PubMed ID: 23008132
[TBL] [Abstract][Full Text] [Related]
19. Impact of donor and recipient IL28B rs12979860 genotypes on hepatitis C virus liver graft reinfection.
Lange CM; Moradpour D; Doehring A; Lehr HA; Müllhaupt B; Bibert S; Bochud PY; Antonino AT; Pascual M; Farnik H; Shi Y; Bechstein WO; Moench C; Hansmann ML; Sarrazin C; Lötsch J; Zeuzem S; Hofmann WP
J Hepatol; 2011 Aug; 55(2):322-7. PubMed ID: 21147186
[TBL] [Abstract][Full Text] [Related]
20. Evolution of fibrosis during HCV recurrence after liver transplantation--influence of IL-28B SNP and response to peg-IFN and ribavirin treatment.
Ackefors M; Nyström J; Wernerson A; Gjertsen H; Sönnerborg A; Weiland O
J Viral Hepat; 2013 Nov; 20(11):770-8. PubMed ID: 24168256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
